---
title: "Allmed: The net profit for 2024 is expected to grow by 176.27% - 221.56% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/226139086.md"
description: "Allmed expects its net profit in 2024 to reach between 305 million yuan and 355 million yuan, a year-on-year increase of 176.27% to 221.56%. The company has increased the market share of traditional products through a long-term strategy and promoted the sales of new products such as functional dressings, driving revenue growth. At the same time, the company made corresponding provisions for impaired assets in 2023, resulting in a lower performance base for 2023"
datetime: "2025-01-24T10:26:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/226139086.md)
  - [en](https://longbridge.com/en/news/226139086.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/226139086.md)
generator: "portal-rs"
---

# Allmed: The net profit for 2024 is expected to grow by 176.27% - 221.56% year-on-year

Allmed released its performance forecast for 2024, expecting a net profit of RMB 305 million to RMB 355 million, an increase of 176.27% to 221.56% compared to the same period last year. In recent years, the company has adhered to long-termism, deployed multiple advanced production capacities, implemented various technological upgrades, and laid out new markets and channels. In 2024, the company achieved an increase in market share for traditional products, boosted sales of functional dressings and other products, and realized revenue growth. At the same time, in 2023, the company made corresponding impairment provisions for assets showing signs of impairment, with a total provision for credit and asset impairment losses amounting to RMB 102.56 million, resulting in a lower performance base for 2023

### Related Stocks

- [002950.CN](https://longbridge.com/en/quote/002950.CN.md)

## Related News & Research

- [CVC Strategic Opportunities makes first outside equity investment in Unitex alongside Potack family](https://longbridge.com/en/news/297911948.md)
- [Align Capital’s Marco Sealing Solutions acquires Global O-Ring and Seal](https://longbridge.com/en/news/297905587.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)
- [10:12 ETOnymos and Vanta Diagnostics Collaborate to Scale Intelligent Lab Intake](https://longbridge.com/en/news/297799488.md)
- [11:58 ETHR HealthCare Launches Liv™ Pre-lubricated Intermittent Catheter for Women](https://longbridge.com/en/news/297938058.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**